Monday, 16 September 2013

Diabetes drug reverses Alzheimer’s and could be available in five years

Results from the Alzheimer’s Society-funded study, led by Professor Christian Hölscher who is now at Lancaster University, show that the drug liraglutide might be able to reverse some of the damage caused by Alzheimer’s disease, even in the later stages of the condition (Lancaster University)

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction

Linagliptin administered in addition to stable RAAS inhibitors led to a significant reduction in albuminuria in patients with type 2 diabetes and renal dysfunction. This observation was independent of changes in glucose level or SBP (Diabetes Care)

Network-Level Structural Abnormalities of Cerebral Cortex in Type 1 Diabetes Mellitus

The current results provide structural evidence for T1DM-related dysfunctional cortical organization, which specifically underlie the top-down cognitive control of language, memory, and emotion (PLoS ONE)

No comments:

Post a Comment